Clinical Trials in Nashville

Showing 4561-4580 of 20,298 trials

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

NCT04629508

This is a 2-part study. In Part 1, participants will be dosed at 2 different dose levels in order to select the RP2D for Part 2 of the study.

MyelofibrosisPolycythemia VeraThrombocythemia

Incyte Corporation4 participantsStarted Jul 2021

New Orleans, Louisiana, United States • Bethesda, Maryland, United States • Kansas City, Missouri, United States +18 more locations

Active Not RecruitingPhase 3< 1 mile

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

NCT03635788

The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA) antiretroviral therapy (ART) and all-oral standard of care (SOC).

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)456 participantsStarted Mar 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +30 more locations

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Find Trials by Condition in Nashville

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Long-Term Evaluation of BIIB067 (Tofersen)

A Study of LY3549492 in Healthy Weight Adult Participants

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Mitral Valve Screening Survey

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy